Search

Your search keyword '"Pyridoxamine pharmacology"' showing total 148 results

Search Constraints

Start Over You searched for: Descriptor "Pyridoxamine pharmacology" Remove constraint Descriptor: "Pyridoxamine pharmacology"
148 results on '"Pyridoxamine pharmacology"'

Search Results

1. Pyridoxamine Alleviates Cardiac Fibrosis and Oxidative Stress in Western Diet-Induced Prediabetic Rats.

2. Behavioral Dysfunctions Caused by Pyridoxamine Deficiency in Drosophila melanogaster.

3. Pyridoxamine protects human granulosa cells against advanced glycation end-products-induced steroidogenesis disturbances.

4. Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial.

5. Evaluation of coronary function in female rats with severe type 1 diabetes: Effects of combined treatment with insulin and pyridoxamine.

6. Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE -/- mice.

7. Pyridoxamine treatment ameliorates large artery stiffening and cerebral artery endothelial dysfunction in old mice.

8. A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases.

9. Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats.

10. Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease.

11. Lactose and Fructo-oligosaccharides Increase Visceral Sensitivity in Mice via Glycation Processes, Increasing Mast Cell Density in Colonic Mucosa.

12. Pyridoxamine alleviates mechanical allodynia by suppressing the spinal receptor for advanced glycation end product-nuclear factor- κ B/extracellular signal-regulated kinase signaling pathway in diabetic rats.

13. Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation.

14. The attenuating effects of pyridoxamine on adipocyte hypertrophy and inflammation differ by adipocyte location.

15. Pyridoxamine Treatment of HK-2 Human Proximal Tubular Epithelial Cells Reduces Oxidative Stress and the Inhibition of Autophagy Induced by High Glucose Levels.

16. Study of pyridoxamine against glycation and reactive oxygen species production in human serum albumin as model protein: An in vitro & ex vivo approach.

17. Inhibition effect of pyridoxamine on lipid hydroperoxide-derived modifications to human serum albumin.

18. The Postprandial Anti-Hyperglycemic Effect of Pyridoxine and Its Derivatives Using In Vitro and In Vivo Animal Models.

19. Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress.

20. The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes.

21. Pyridoxamine scavenges protein carbonyls and inhibits protein aggregation in oxidative stress-induced human HepG2 hepatocytes.

22. Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction.

23. Effect of Scavenging Circulating Reactive Carbonyls by Oral Pyridoxamine in Uremic Rats on Peritoneal Dialysis.

24. Reactivity, Selectivity, and Reaction Mechanisms of Aminoguanidine, Hydralazine, Pyridoxamine, and Carnosine as Sequestering Agents of Reactive Carbonyl Species: A Comparative Study.

25. Effect and mechanism of pyridoxamine on the lipid peroxidation and stability of polyunsaturated fatty acids in beef patties.

26. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.

27. Protective function of pyridoxamine on retinal photoreceptor cells via activation of the p‑Erk1/2/Nrf2/Trx/ASK1 signalling pathway in diabetic mice.

28. Pyridoxamine protects proteins from damage by hypohalous acids in vitro and in vivo.

29. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.

30. Advanced glycation end products induced immune maturation of dendritic cells controls heart failure through NF-κB signaling pathway.

31. Protective Effects of Pyridoxamine Against UVC-induced Programmed Cell Death in HaCaT Cells.

32. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.

33. Effects of methylglyoxal and pyridoxamine in rat brain mitochondria bioenergetics and oxidative status.

34. Pyridoxamine reverts methylglyoxal-induced impairment of survival pathways during heart ischemia.

35. Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light.

36. Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.

37. Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy.

38. Advanced glycation end products and diabetic retinopathy.

39. Combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes.

40. Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes.

41. Generation of superoxide anions by a glycation reaction in conventional laboratory media.

42. [Effect of telmisartan and pyridoxamine on oxidative stress in brain tissue of spontaneously hypertensive rats].

43. Synergistic effects of telmisartan and pyridoxamine on early renal damage in spontaneously hypertensive rats.

44. Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.

45. Vitamin B6: beyond coenzyme functions.

46. Rescuing hepatocytes from iron-catalyzed oxidative stress using vitamins B1 and B6.

47. [Effects of telmisartan and pyridoxamine on abdominal aorta vascular remodeling in spontaneously hypertensive rats].

48. Pyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycation.

49. Glycation of the muscle-specific enolase by reactive carbonyls: effect of temperature and the protection role of carnosine, pyridoxamine and phosphatidylserine.

50. Potential new therapeutic agents for diabetic kidney disease.

Catalog

Books, media, physical & digital resources